Pharmacokinetics and pharmacodynamics of multiple weekly subcutaneous efalizumab doses in patients with plaque psoriasis.

Mortensen, Deborah L; Walicke, Patricia A; Wang, Xiaolin; Kwon, Paul; Kuebler, Peter; Gottlieb, Alice B; Krueger, James G; Leonardi, Craig; Miller, Bruce; Joshi, Amita

Mortensen, Deborah L; Walicke, Patricia A; Wang, Xiaolin; Kwon, Paul; Kuebler, Peter; Gottlieb, Alice B; Krueger, James G; Leonardi, Craig; Miller, Bruce; Joshi, Amita.

Affiliation

Mortensen DL; Genentech, Inc, 1 DNA Way, South San Francisco, CA 94080-4990, USA.

J Clin Pharmacol ; 45(3): 286-98, 2005 Mar.

Article de En | MEDLINE | ID: mdl-15703364

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Psoriasis / Antigènes CD11a / Anticorps monoclonaux Type d'étude: Clinical_trials Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Clin Pharmacol Année: 2005 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links